Cargando…

Targeted proteomics of right heart adaptation to pulmonary arterial hypertension

No prior proteomic screening study has centred on the right ventricle (RV) in pulmonary arterial hypertension (PAH). This study investigates the circulating proteomic profile associated with right heart maladaptive phenotype (RHMP) in PAH. Plasma proteomic profiling was performed using multiplex imm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amsallem, Myriam, Sweatt, Andrew J., Arthur Ataam, Jennifer, Guihaire, Julien, Lecerf, Florence, Lambert, Mélanie, Ghigna, Maria Rosa, Ali, Md Khadem, Mao, Yuqiang, Fadel, Elie, Rabinovitch, Marlene, de Jesus Perez, Vinicio, Spiekerkoetter, Edda, Mercier, Olaf, Haddad, Francois, Zamanian, Roham T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8029214/ https://www.ncbi.nlm.nih.gov/pubmed/33334941 http://dx.doi.org/10.1183/13993003.02428-2020

Ejemplares similares

Current Knowledge and Recent Advances of Right Ventricular Molecular Biology and Metabolism from Congenital Heart Disease to Chronic Pulmonary Hypertension
por: Guimaron, Samantha, et al.
Publicado: (2018)

Echocardiographic evaluations of right ventriculo–arterial coupling in experimental and clinical pulmonary hypertension
por: Boulate, David, et al.
Publicado: (2019)

Quantifying the Influence of Wedge Pressure, Age, and Heart Rate on the Systolic Thresholds for Detection of Pulmonary Hypertension
por: Amsallem, Myriam, et al.
Publicado: (2020)

Stem cell therapy targeting the right ventricle in pulmonary arterial hypertension: is it a potential avenue of therapy?
por: Loisel, Fanny, et al.
Publicado: (2018)

The Right Heart Network and Risk Stratification in Pulmonary Arterial Hypertension
por: Haddad, Francois, et al.
Publicado: (2022)

Hemodynamic trajectories and outcomes in patients with pulmonary arterial hypertension
por: Amsallem, Myriam, et al.
Publicado: (2020)

Non-invasive right ventricular load adaptability indices in patients with scleroderma-associated pulmonary arterial hypertension
por: French, Sarah, et al.
Publicado: (2018)

Myocardial bridge: an unrecognized cause of chest pain in pulmonary arterial hypertension
por: Rajmohan, Divya, et al.
Publicado: (2020)

A case of recurrent pericardial constriction presenting with severe pulmonary hypertension
por: Brunner, Nathan W., et al.
Publicado: (2013)

Severe Pulmonary Arterial Hypertension Is Characterized by Increased Neutrophil Elastase and Relative Elafin Deficiency
por: Sweatt, Andrew J., et al.
Publicado: (2021)

Role of Long Non-Coding RNAs in Pulmonary Arterial Hypertension
por: Han, Yun, et al.
Publicado: (2021)

Diagnosis and management of pulmonary hypertension associated with left ventricular diastolic dysfunction
por: Perez, Vinicio A. de Jesus, et al.
Publicado: (2012)

The Role of Neutrophils and Neutrophil Elastase in Pulmonary Arterial Hypertension
por: Taylor, Shalina, et al.
Publicado: (2018)

Decreasing ELK3 expression improves Bone Morphogenetic Protein Receptor 2 signaling and pulmonary vascular cell function in PAH
por: Ali, Md Khadem, et al.
Publicado: (2023)

Targeting BMPR2 Trafficking with Chaperones: An Important Step toward Precision Medicine in Pulmonary Arterial Hypertension
por: Andruska, Adam, et al.
Publicado: (2020)

Exome data clouds the pathogenicity of genetic variants in Pulmonary Arterial Hypertension
por: Abbasi, Yeganeh, et al.
Publicado: (2018)

Novel Advances in Modifying BMPR2 Signaling in PAH
por: Dannewitz Prosseda, Svenja, et al.
Publicado: (2020)

Novel left ventricular mechanical index in pulmonary arterial hypertension
por: Ichimura, Kenzo, et al.
Publicado: (2023)

Sex Differences in Immunology: More Severe Development of Experimental Pulmonary Hypertension in Male Rats Exposed to Vascular Endothelial Growth Factor Receptor Blockade
por: Guihaire, Julien, et al.
Publicado: (2015)

Cardiac Fibrosis in the Pressure Overloaded Left and Right Ventricle as a Therapeutic Target
por: Schimmel, Katharina, et al.
Publicado: (2022)

The Beneficial Effect of Suramin on Monocrotaline-Induced Pulmonary Hypertension in Rats
por: Izikki, Mohamed, et al.
Publicado: (2013)

Smooth Muscle Phenotype in Idiopathic Pulmonary Hypertension: Hyper-Proliferative but not Cancerous
por: Perros, Frédéric, et al.
Publicado: (2019)

Elucidating tricuspid Doppler signal interpolation and its implication for assessing pulmonary hypertension
por: Dual, Seraina A., et al.
Publicado: (2022)

4D flow cardiovascular magnetic resonance recovery profiles following pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension
por: Dong, Melody L., et al.
Publicado: (2022)

Methamphetamine use association with pulmonary diseases: a retrospective investigation of hospital discharges in California from 2005 to 2011
por: Tsai, Halley, et al.
Publicado: (2019)

BMP promotes motility and represses growth of smooth muscle cells by activation of tandem Wnt pathways
por: de Jesus Perez, Vinicio A., et al.
Publicado: (2011)

Comparative analysis on the anti-inflammatory/immune effect of mesenchymal stem cell therapy for the treatment of pulmonary arterial hypertension
por: Oh, Seyeon, et al.
Publicado: (2021)

Description, Staging and Quantification of Pulmonary Artery Angiophagy in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension
por: Perros, Frédéric, et al.
Publicado: (2020)

Prescription Patterns for Pulmonary Vasodilators in the Treatment of Pulmonary Hypertension Associated With Chronic Lung Diseases: Insights From a Clinician Survey
por: Thomas, Christopher A., et al.
Publicado: (2021)

Reply to Andréasson et al.: Multiple Manifestations of Systemic Sclerosis Affect Walk Distance
por: Zamanian, Roham T., et al.
Publicado: (2021)

Consequences of BMPR2 Deficiency in the Pulmonary Vasculature and Beyond: Contributions to Pulmonary Arterial Hypertension
por: Andruska, Adam, et al.
Publicado: (2018)

Right Ventricle Remodeling Metabolic Signature in Experimental Pulmonary Hypertension Models of Chronic Hypoxia and Monocrotaline Exposure
por: Hautbergue, Thaïs, et al.
Publicado: (2021)

Outpatient Inhaled Nitric Oxide in a Patient with Vasoreactive Idiopathic Pulmonary Arterial Hypertension and COVID-19 Infection
por: Zamanian, Roham T., et al.
Publicado: (2020)

Role of adjuvant radiotherapy in completely resected non-small-cell lung cancer
por: Péchoux, Cecile Le, et al.
Publicado: (2013)

Causes and Consequences of miR-150-5p Dysregulation in Myasthenia Gravis
por: Cron, Mélanie A., et al.
Publicado: (2019)

Arteriovenous Malformations—Current Understanding of the Pathogenesis with Implications for Treatment
por: Schimmel, Katharina, et al.
Publicado: (2021)

PTPN1 Deficiency Modulates BMPR2 Signaling and Induces Endothelial Dysfunction in Pulmonary Arterial Hypertension
por: Ali, Md Khadem, et al.
Publicado: (2023)

Computational platform for doctor–artificial intelligence cooperation in pulmonary arterial hypertension prognostication: a pilot study
por: Kheyfets, Vitaly O., et al.
Publicado: (2023)

Reduced BMPR2 expression induces GM-CSF translation and macrophage recruitment in humans and mice to exacerbate pulmonary hypertension
por: Sawada, Hirofumi, et al.
Publicado: (2014)

Decreased expression of miR-29 family associated with autoimmune myasthenia gravis
por: Cron, Mélanie A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v69alu385v4qkqht2b6uekttum